Next Generation Partner ‒ Capital Markets: Equity Offerings
The Legal 500 US 2024
"Alison is a fantastic attorney, extremely dedicated and gives great advice with great judgment."
Chambers USA 2022
"Alison is strong within this market."
Chambers USA 2023
"A very personable and good lawyer."
Chambers USA 2022
"She is a rising star in equity capital markets."
Chambers USA 2021
Profile
Alison Haggerty advises issuers and investment banking firms in capital markets transactions, with a focus on initial public offerings, follow-on equity offerings, and convertible debt offerings in growth industries.
Alison serves a mix of companies and financial institutions in connection with complex equity and debt securities offerings. She brings particular experience handling capital markets transactions on behalf of all of the major US investment banks and leading innovators in technology, healthcare and life sciences, and retail and consumer products.
Alison also regularly counsels publicly traded companies on general corporate and securities law matters, including governance issues, reporting obligations, and stock exchange rules and requirements.
Experience
Alison’s representative experience includes advising the issuer or underwriters in connection with securities offerings for the following companies:
ADC Therapeutics*
Aquantia
Axovant
Cara Therapeutics
Catabasis*
Datadog
Duolingo
Etsy
European Wax Center
Everyday Health
FIGS
Fluence Energy
Imara*
Immunovant*
MongoDB
Monte Rosa
Myovant Sciences
ODDITY Tech
Ovid
Prevail Therapeutics
Progyny
RenalytixAI*
Rivian
Roivant
Schrodinger*
Strongbridge Biopharma*
WAVE Life Sciences*
Zentalis Pharmaceuticals*
*Client represented prior to joining Latham
Qualifications
Bar Qualification
New York
Education
JD, New York University School of Law, 2010 cum laude
BS, University of North Carolina, Chapel Hill, 2004
Latham & Watkins capital markets partner Alison Haggerty has steered some of the most intriguing and largest initial public offerings over the last few years, including Rivian Automotive's US$11.9 billion IPO in 2021, earning her a spot as one of the capital markets attorneys under age 40 honored by Law360 as Rising Stars.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.